-
STAT News – Biotech3 months agoSTAT+: U.K. to take another look at cost-effectiveness of Alzheimer’s drugs
LONDON — U.K. health officials on Friday said they had reopened a review of two new Alzheimer’s therapies after previously finding they did not provide good...
-
Uncategorized3 months agoLilly wins appeal for donanemab, drug to be reconsidered for NHS
Eli Lilly’s appeal against guidance which did not recommend donanemab has been upheld, forcing authorities to reconsider the drug for NHS use. The National Institute for...
-
Endpoints News3 months ago
Idorsia looks for another CEO — again; Former Jazz exec makes a comeback
→ Srishti Gupta took over as CEO of Idorsia last summer, but the job is open again as chairman Jean-Paul Clozel kicks off another search. Idorsia’s...
-
Endpoints News3 months ago
Genentech culls muscle-preserving drug in genetic diseases, raising questions about obesity trial
Roche’s subsidiary Genentech has called off the late-stage development of a muscle-building drug in two rare genetic conditions, spinal muscular atrophy (SMA) and facioscapulohumeral muscular dystrophy...
-
Fierce Biotech3 months ago
Behind the curtain: What Xaira is building after its $1B fundraise
What has Xaira been doing since its $1 billion raise? Xaira COO Jeff Jonker joins “The Top Line” to talk strategy, AI and the company’s long-game...
-
Fierce Biotech3 months ago
Intuitive recalls surgical stapler reloads following patient death
This comes in the same week that Intuitive reported a cyberattack, with a phishing incident targeting some of its employees.
-
Uncategorized3 months agoFDA finds lack of evidence for dry eye disease drug approval
Aldeyra Therapeutics has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for the New Drug Application (NDA) of reproxalap, an...
-
Uncategorized3 months agoTGA approves trial for first-in-human multiple myeloma therapy
Australia’s Therapeutic Goods Administration (TGA) has approved a first-in-human trial of a T-cell therapy in multiple myeloma. The therapy, developed by HaemaLogiX in collaboration with the Peter MacCallum...
-
STAT News – Biotech3 months agoSTAT+: A family’s giving to the Broad Institute’s research tops $1 billion
The Broad Institute of MIT and Harvard is poised to receive a massive injection of cash to fund breakthroughs in the understanding and treatment of bipolar disorder and...
-
STAT News – Biotech3 months agoTobacco could get a boost from the farm bill. How does that square with MAHA?
The 2026 farm bill now working its way through Congress contains a number of provisions at odds with the Make America Healthy Again movement, particularly when...
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
